Seeking a common human factors language for the development and testing of injection devices.

IF 8.1 2区 医学 Q1 PHARMACOLOGY & PHARMACY
Drug Delivery Pub Date : 2025-12-01 Epub Date: 2025-08-07 DOI:10.1080/10717544.2025.2541660
Megan O Conrad, Molly E Laird, Mary Beth Privitera, Melissa R Lemke, Molly Follette Story
{"title":"Seeking a common human factors language for the development and testing of injection devices.","authors":"Megan O Conrad, Molly E Laird, Mary Beth Privitera, Melissa R Lemke, Molly Follette Story","doi":"10.1080/10717544.2025.2541660","DOIUrl":null,"url":null,"abstract":"<p><p>Injection devices include drug-device combination products incorporating a needle for subcutaneous medication delivery. Often utilized by patients and caregivers, it is important for injection device user interface (UI) design to be intuitive to use outside of a traditional healthcare setting. To ensure safety and efficacy, the FDA requires a human factors (HFs) assessment as part of a new drug application (NDA) for new drug products and through the abbreviated new drug application (ANDA) pathway for generic drug approval. Despite the importance of defining injection device features as part of the HFs assessment, no comprehensive list of related definitions has previously been established. This paper compiles such definitions creating a common language for use in HFs assessments. Specifically, injection device classifications and characteristics are defined and then related to UI features and common tasks required for successful devices use. Information presented can be applied during device development and testing creating a common language for engineers, designers, and regulators. The definitions may be especially impactful for the approval of generic injection devices as the ANDA pathway for generic drugs requires a UI comparison of the proposed generic device to that of the existing reference listed drug.</p>","PeriodicalId":11679,"journal":{"name":"Drug Delivery","volume":"32 1","pages":"2541660"},"PeriodicalIF":8.1000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12333034/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Delivery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/10717544.2025.2541660","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/7 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Injection devices include drug-device combination products incorporating a needle for subcutaneous medication delivery. Often utilized by patients and caregivers, it is important for injection device user interface (UI) design to be intuitive to use outside of a traditional healthcare setting. To ensure safety and efficacy, the FDA requires a human factors (HFs) assessment as part of a new drug application (NDA) for new drug products and through the abbreviated new drug application (ANDA) pathway for generic drug approval. Despite the importance of defining injection device features as part of the HFs assessment, no comprehensive list of related definitions has previously been established. This paper compiles such definitions creating a common language for use in HFs assessments. Specifically, injection device classifications and characteristics are defined and then related to UI features and common tasks required for successful devices use. Information presented can be applied during device development and testing creating a common language for engineers, designers, and regulators. The definitions may be especially impactful for the approval of generic injection devices as the ANDA pathway for generic drugs requires a UI comparison of the proposed generic device to that of the existing reference listed drug.

Abstract Image

为注射设备的开发和测试寻找一种通用的人为因素语言。
注射装置包括包含用于皮下给药的针的药物装置组合产品。通常由患者和护理人员使用,注射设备用户界面(UI)设计要直观,以便在传统医疗保健环境之外使用,这一点很重要。为了确保安全性和有效性,FDA要求将人为因素(HFs)评估作为新药申请(NDA)的一部分,并通过仿制药批准的简略新药申请(ANDA)途径进行评估。尽管将注射装置特征定义为HFs评估的一部分很重要,但之前没有建立相关定义的综合清单。本文汇编了这些定义,为hfcs评估创造了一种通用语言。具体来说,定义了注射设备的分类和特征,然后与成功使用设备所需的UI功能和常见任务相关。所提供的信息可以在设备开发和测试期间应用,为工程师,设计师和监管机构创建通用语言。这些定义可能对仿制注射器械的批准特别有影响,因为仿制药的ANDA途径需要将拟议的仿制器械与现有参考上市药物进行UI比较。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Drug Delivery
Drug Delivery 医学-药学
CiteScore
11.80
自引率
5.00%
发文量
250
审稿时长
3.3 months
期刊介绍: Drug Delivery is an open access journal serving the academic and industrial communities with peer reviewed coverage of basic research, development, and application principles of drug delivery and targeting at molecular, cellular, and higher levels. Topics covered include all delivery systems including oral, pulmonary, nasal, parenteral and transdermal, and modes of entry such as controlled release systems; microcapsules, liposomes, vesicles, and macromolecular conjugates; antibody targeting; protein/peptide delivery; DNA, oligonucleotide and siRNA delivery. Papers on drug dosage forms and their optimization will not be considered unless they directly relate to the original drug delivery issues. Published articles present original research and critical reviews.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信